Navigation Links
Novelda Appoints Alf-Egil Bogen as Chief Executive Officer to Lead the Company to the Next Level
Date:8/22/2013

OSLO, Norway, Aug. 22, 2013 /PRNewswire/ -- Novelda, the provider of Nanoscale Impulse Radar solutions, announces the appointment of Alf-Egil Bogen as Chief Executive Officer. Bogen, one of the inventors of the successful AVR Microcontroller, has been in the semiconductor industry for over 20 years and most recently served as CMO for Atmel Corporation where he was based in San Jose, California and as CMO for Energy Micro, assisting the sale of the company to Silicon Labs in Texas.

(Photo: http://photos.prnewswire.com/prnh/20130822/PH67741-a )

(Logo: http://photos.prnewswire.com/prnh/20130822/PH67741LOGO-b )

"I am very excited to work for Novelda. Their proprietary CMOS chips for radar solutions open up a new world of opportunities. Not only can it see objects, but it can also see through them!" says Alf-Egil Bogen. "I have been on their board for a while, and also invested money in the company, so I really believe in the company. Dag Wisland and his team have done a great job and established a very impressive customer base for this product. I am looking forward to working with Dag to take Novelda to next level," he continues.

Dag T. Wisland will be the President for the company and will focus more on R&D moving forward. Dag is one of the founders of Novelda and says this about getting Bogen on board: "Alf-Egil Bogen has the combination of technical and business experience we need to take the next step. His long semiconductor experience and the ability to get good results are very impressive. The entire team is excited about this, and we look forward to working with him."

"Our strategy for the company involves a strong focus on turnkey solutions for our OEM customers. We want to help them in the design of amazing radars for medical, building automation, robots and many other applications. I am also proud of the relationship with Samsung Thales to search for land mines. If we can help saving lives with our technology that will feel very right," Bogen finishes.

ABOUT NOVELDA AS

Novelda AS is a privately held, R&D driven, Semiconductor Company, based in Norway and specializing in nanoscale wireless low-power technology for ultra-high resolution impulse radar.

The Novelda Impulse Radar is a complete CMOS radar system integrated on a single chip: a sensor for human vital sign monitoring, personal security, environmental monitoring, industrial automation and robotics. In addition to being an alternative to, or complementing existing technologies such as video, ultrasound and infrared sensors, it opens up for new application areas due to its speed and resolution, and its ability to "see through" obstacles.

Novelda was founded in 2004 as a spinout from the University of Oslo, and there is a strong Research & Development partnership with the university. www.novelda.no

High-resolution image:

Press Release Contact:   
President Dag Wisland: dag(at)novelda.no 
CMO Aage Kalsaeg: aage(at)novelda.no

Read more news from Novelda.               


'/>"/>
SOURCE Novelda AS
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. State-of-the-Art Novelda NVA6000 Impulse Radar Transceiver Finds Widespread Appeal and Applications
2. Samsung Thales signs Development Agreement with Novelda
3. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
4. Elsevier / MEDai Appoints Tom Zajac as New President
5. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
6. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
7. BioStorage Technologies Appoints New Member to Board of Directors
8. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
9. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
10. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
11. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseqâ„¢ ... developed with input from industry experts to ...
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
Breaking Biology Technology:
(Date:3/22/2017)... March 21, 2017 Optimove , ... by retailers such as 1-800-Flowers and AdoreMe, today ... Recommendations and Replenishment. Using Optimove,s machine learning algorithms, ... product and replenishment recommendations to their customers based ... predictions of customer intent drawn from a complex ...
(Date:3/16/2017)... - Against identity fraud with DERMALOG solutions "Made in Germany "  ... ... multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog Identification Systems) ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity ... ...
(Date:3/7/2017)... Brandwatch , the leading social intelligence company, today announces that it ... insights to support its reporting, help direct future campaigns, and share ... charity will be using Brandwatch Analytics social listening and analytics technology ... the topics and issues that are a priority for its supporters. ... "Until recently we,ve ...
Breaking Biology News(10 mins):